In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Edwards Lifesciences Corp.

https://www.edwards.com/gb

Latest From Edwards Lifesciences Corp.

Cardio Catch-Up: Registry Data Spurs Discussion On TAVR For Asymptomatic Patients

Results from the TVT Registry suggest that TAVR may benefit patients who have severe aortic disease but few symptoms. Clinical trials specifically designed to answer that question are needed, according to an editorial in JACC

Clinical Trials Commercial

News We’re Watching: AHA Meeting In Philly; Surgeons Call For TAVR Caution; China Approves J&J's Monarch Robot

New clinical trial data presented at the American Heart Association Scientific Sessions in Philadelphia dominated the R&D news this week. Here are some of the highlights from the conference as well as some other bits of medtech industry news you may have missed.

News We're Watching Approvals

News We're Watching: TCT Yields More Encouraging Results For TAVR; HeartPoint Resets Trial Plans, Butterfly Tries Brain-Interface Tech

Clinical trial results announced at the Transcatheter Therapeutics conference in San Francisco headlined the medtech research and development news last week. Noteworthy "commercial" developments in late October include iCad’s decision to sell its Xoft brachytherapy business to Elekta and Butterfly Network's plans to work with Forest Neurotech on brain-computer interfaces.

News We're Watching Clinical Trials

Why Investing In ESG Measures Is Good For Medtech’s Health And Sustainability

For medtechs, implementing an ESG strategy will need to become a priority as global rules are being introduced for companies to report ESG data. A panel discussion with medtech ESG leaders at the recent LSX Congress USA conference in Boston outlined some strategies and sustainability goals.

Sustainability Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Infusion Therapy Equipment and Supplies
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • CardiAQ Valve Technologies, Inc.
    • CAS Medical Systems, Inc.
    • Embrella Cardiovascular, Inc.
    • Harpoon Medical, Inc.
    • Percutaneous Valve Technologies, Inc.
    • Valtech Cardio, Ltd.
UsernamePublicRestriction

Register